just a buyback at the friendly fair market price.
shorts
2013-08-31 1,225,348 402,848 105,890,404 1.16%
2013-08-15 822,500 822,500 105,890,404 0.78%
So Urocidin will be approved only in which country first? Will Urocidin be part of that special club?
Of 584 new therapeutic drugs approved in the 20- year period that satisfied the study definition, 554 (94.7%) were approved in the US and 484 (82.9%) in Canada; 454 (77.7%) were approved in both countries. In each country, the median review time for the country-specific drugs was generally longer than that for the drugs approved in both countries (Appendices A and B), but the only difference that was marginally statistically significant was in priority status drugs in Canada. Nevertheless, the drugs approved in Canada alone constituted just 6.2% of all drugs approved in the country and only varied between 2.1% and 11.0% across the four approval periods, whereas in the US, the corresponding rate was 18.1%, which increased sharply from 8.0% to 36.8% across the four periods.
Of the 454 drugs, 385 (84.8%) were submitted and 386 (85.0%) approved first in the US.
https://www.ncbi.nlm.nih.gov/pubmed/23650206